NSF Pharma Biotech’s CEO Martin Lush recently had a meeting with a CEO to help solve his company’s pain points.
He was in need of a big dose of a strong analgesic. Falling prices, suffocating complexity, poor product development, supply chain disruption, product shortages, increasing operational costs and unhappy investors were taking him beyond his pain threshold. One pain point jumped off the screen: poor recruitment and retention. They had an attrition rate of 14%.